Literature DB >> 25816744

Factors impact the adherence rate of prophylaxis for deep venous thrombosis in acute ischaemic stroke patients: an analysis of the China National Stroke Registry.

Zixiao Li, Liping Liu, Yilong Wang, Xingquan Zhao, David Z Wang, Chunxue Wang, Hao Li, Chunjuan Wang, Haiqiang Qin, Xianwei Wang, Yongjun Wang.   

Abstract

OBJECTIVES: Little is known about the clinical practice of deep venous thrombosis (DVT) prophylaxis in patients with acute ischaemic stroke in China. We examined the factors that impact the adherence rate of DVT prophylaxis in stroke patients from the China National Stroke Registry (CNSR).
METHODS: Records of 12 173 acute ischaemic stroke patients with follow-up admitted to 132 hospitals in CNSR from September 1, 2007 to August 30, 2008 were reviewed. Data from 4643 patients eligible for DVT prophylaxis were analysed. Generalised estimating equations were used to identify the patient's and hospital's factors that impact the practice of DVT prophylaxis.
RESULTS: Among 4643 acute ischaemic stroke patients eligible for DVT prophylaxis, the overall adherence rate of DVT prophylaxis was 59·6%. The median hospital prophylaxis rate was 57·8% (inter quartile range: 33·3(70·2%). Venous thromboembolism was found in 1·6% of patients. Factors associated with increased likelihood of practicing DVT prophylaxis in the multivariable model included history of atrial fibrillation (AF) (P = 0·04), receiving rehabilitation evaluation (P < 0·001), receiving care in the East (P < 0.001) or Central (P = 0.001) regions compared to west regions of China. Increasing age (P = 0.014), NIHSS score on admission (P < 0.001), annual stroke discharges (P = 0.001), and the hospital size (P = 0.003) were associated with lower likelihood of DVT prophylaxis. DISCUSSION: The adherence rate of DVT prophylaxis among non-ambulance patients with acute ischaemic stroke was suboptimal in China. It varied among patients by age, stroke severity, and history of AF, and among hospitals by different locations, number of beds and annual stroke discharges.

Entities:  

Keywords:  Acute stroke,; Deep venous thrombosis,; Treatment variations

Mesh:

Year:  2015        PMID: 25816744     DOI: 10.1179/1743132815Y.0000000035

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  4 in total

Review 1.  Deep Vein Thrombosis in Acute Stroke - A Systemic Review of the Literature.

Authors:  Muhammad T Khan; Asad Ikram; Omar Saeed; Taha Afridi; Cathy A Sila; Matthew S Smith; Khadija Irshad; Ashfaq Shuaib
Journal:  Cureus       Date:  2017-12-23

2.  Clinical Risk Factors of Asymptomatic Deep Venous Thrombosis in Patients With Acute Stroke.

Authors:  Yi Wang; Yu Shi; Yi Dong; Qiang Dong; Ting Ye; Kun Fang
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

3.  Evaluation of a Multilevel Program to Improve Clinician Adherence to Management Guidelines for Acute Ischemic Stroke.

Authors:  Yi Chen; Xiaoxian Gong; Wansi Zhong; Jianbing Wang; Zongming Yang; Shenqiang Yan; Fangli Geng; Ying Zhou; Xuting Zhang; Zhicai Chen; Haitao Hu; Lusha Tong; Hongfang Chen; Shaofa Ke; Yuping He; Yaxian Wang; Xiaoling Zhang; Zhimin Wang; Zhihui Chen; Heng Zhao; Changzheng Yuan; Min Lou
Journal:  JAMA Netw Open       Date:  2022-05-02

4.  Deep vein thrombosis inhibitor may play a therapeutic role in post-stroke patients.

Authors:  Xixi Xiang; Di Yuan; Peiyan Kong; Ting Chen; Han Yao; Shijia Lin; Xi Zhang; Hongbao Cao
Journal:  BMC Med Genet       Date:  2020-10-22       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.